期刊文献+

低钙透析对高凝血液透析患者凝血系统的影响 被引量:3

Effects of maintenance hemodialysis with low-calcium dialysis solutions on blood coagulation system in hypercoagulable patients
下载PDF
导出
摘要 目的:研究低钙透析对处于高凝状态的维持性血液透析(MHD)患者凝血系统的影响。方法:根据透析液钙离子浓度,48例高凝MHD患者被随机分为3组:钙离子浓度1.25 mmol/L(Dca 1.25)的16例,1.50 mmol/L(Dca 1.5)的18例,1.75mmol/L(Dca 1.75)的14例,透析液其他成分不变。3组患者每次透析4.5 h,共透析1月。监测透析前后血小板(PLT)、活化部分凝血酶原时间(APTT)、凝血酶原时间(PT)、纤维蛋白原(FIB)。结果:透析后Dca 1.25组FIB(5.07±0.94)g/L比Dca1.5组的FIB(6.08±1.49)g/L明显下降(P<0.05),比Dca 1.75组的FIB(5.82±0.98)g/L也明显改善(P<0.05);而Dca1.5组和Dca 1.75组的FIB比较则无显著性差异(P>0.05)。Dca 1.25组在透析前后FIB有显著性差异(P<0.01)。3组透析后PLT、APTT、PT均无明显差异(P>0.05)。结论:低钙透析能够改善维持性血透患者的高凝状态,降低出血及凝血风险。 Objective:To investigate the effects of maintenance hemodialysis (MHD) with low -calcium dialysis solutions on blood coagulation system in hypercoagulable patients. Methods: According to the serum calcium concentration, 48 hypercoagulable MHD patients were randomly divided into three groups : 1.25 mmol/L group (n = 16), 1.5 mmol/L group ( n = 18) and 1.75mmol/L group ( n = 14). Other components of dialysate were invariable. The hemodialysis time was 4.5 hours every time and the observation time was one month. The platelets (PLT), activated partial thromboplastin time (APTT), prothrombin time (PT) and fibrinolysis (FIB) were detected before and after hemodialysis. Results: After hemodialysis, the FIB concentrations in Dca 1.25, 1.5, and 1.75 groups were 5.07 ± 0.94 g/L, 6.08 ± 1.49 g/L, and 5.82 ± 0.98 g/L respectively (P 〈 0.05, Dca 1.25 group vs other groups). There was significant difference in the FIB concentration between pre - and post - hemodialysis in all groups ( P 〈 0.01 ). There was no significant change in the PLT, APTT and PT levels after hemodialysis(P 〉 0.05 ). Conclusion: The low- calcium dialysis could improve hypercoagulability state and reduce the risk of hemorrhage for hypercoagulable MHD patients.
机构地区 解放军第 解放军第
出处 《西北国防医学杂志》 CAS 2009年第5期340-342,共3页 Medical Journal of National Defending Forces in Northwest China
基金 兰州军区医药卫生科研计划资助项目(LXH-2006015)
关键词 血液透析 低钙透析液 凝血系统 高凝 Hemodialysis Low - calcium dialysate Blood coagulation system Hypercoagulability
  • 相关文献

参考文献6

二级参考文献54

  • 1李芸,丁峰,顾勇,薛骏,李铭新,施雪枫,陆福明,林善锬.维持性血液透析患者钙、磷代谢的变化[J].上海医学,2004,27(8):552-555. 被引量:3
  • 2潘学谊,丁彩屏,钟亮伊,黄旭明,周万兴,郭煜,尹金柱,蔡小燕,关则兵,张柔玲.蛋白质Z检测在心脑血管疾病中的临床意义[J].中华血液学杂志,2004,25(11):671-674. 被引量:18
  • 3芮海荣,赵养俊,柳淑惠,刘静琳,王章华.低钙透析在维持性血液透析患者骨化三醇冲击治疗中的应用[J].中国血液净化,2005,4(8):452-452. 被引量:10
  • 4芮海荣,赵养俊,柳淑惠,王章华.罗钙全冲击治疗过程中伴巨大转移性钙化1例报道[J].中国血液净化,2006,5(11):782-782. 被引量:1
  • 5[1]Nakamura Y,Chida Y,Tomura S,et al.Enhanced coagulation-fibrinolytic in patients on regular hemodialysis treatment.Nephron,1991,58:201~204
  • 6[2]Patrice M A,Rudolf P W,Korte W,et al.Plasma hypercoagulability in haemodialysis patients:Impact of dialysis and anticoagulation.Nephrol Dial Transplant,1997,12:2355~2364
  • 7[3]Ishii Y,Yano S,Kanai H,et al.Evaluation of blood coagulation-fibrinolysis system in patients receiving chronic hemodialysis.Nephron,1996,73:407~412
  • 8[4]Seyfert U T,Helmling E,Hanck W,et al.Comparison of blood biocompatibility during haemodialysis with cuprophane and polacrylonitrile membrane.Nephrol Dial Transplant,1991,6:428~434
  • 9[5]Ireland H A,Boisclair M D,Lane D A,et al.Hemodialysis and heparin.Alternative methods of measuring heparin and of detecting activation of coagulation.Clin Nephrol,1991,35:26~34
  • 10Usalan C, Erdem Y, Ahun B, et al. Protein Z levels in haemodialysis patient[J]. Int Urol Nephrol, 1999, 31(4):541-5.

共引文献24

同被引文献30

  • 1季大玺.连续性血液净化与重症感染[J].肾脏病与透析肾移植杂志,2004,13(3):235-236. 被引量:58
  • 2卢文,郝丽,司力.肾病综合征患者凝血分子标志物测定的临床价值[J].实用医学杂志,2005,21(7):682-684. 被引量:8
  • 3Kingston JK, BayVIY WM, Sellon DC,et al. Effects of sodium cit rate, low molecular weight heparin, and prostaglandin E1 on ag gregation, fibrinogen binding, and enumeration of equine platelets[J]. AM J Vet Res,2001,62(4) :547-554.
  • 4Canaud B, Desmeules S, Klouche K, et al. Vascular access for dialysis in the intensive care unit [ J ]. Best Pract Res Clin Anaesthesiol, Mar 2004,18(1) :159 -174.
  • 5Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy : a randomized controlled trial [ J ]. Jama, 2008,299 (20) :2413 - 2422.
  • 6Leblanc M, Fedak S, Mokris G, et al. Blood recirculation in temporary central catheters for acute hemodialysis[J]. Clin Nephrol, 1996,45 (5) :315 -319.
  • 7Davies H, Leslie G. Maintaining the CRRT circuit:non-anticoagulant al- ternatives [ J ]. Aust Crit Care ,2006,19 (4) : 133 - 138.
  • 8Ramesh Prasad GV, Palevsky PM, Burr R, et al. Factors affecting sys- tem clotting in continuous renal replacement therapy : results of a ran- domized, controlled trial[ J]. Clin Nephro1,2000,53 ( 1 ) :55 - 60.
  • 9van der Voort PH, Gerritsen RT, Kuiper MA, et al. Filter run time in CVVH:pre-versus post-dilution and nadroparin versus regional hepa- rin-protamine anticoagulation[ J ]. Blood Purif, 2005,23 ( 3 ) : 175 - 180.
  • 10de Pont AC, Bouman CS, Bakhtiari K, et al. Predilution versus postdi- lution during continuous venovenous hemofihration: a comparison of circuit thrombogenesis[J]. Asaio J,2006,52 (4) :416 - 422.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部